N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 2.812 NOK 4.38% Market Closed
Market Cap: 918.2m NOK
Have any thoughts about
Nykode Therapeutics ASA?
Write Note

Nykode Therapeutics ASA
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nykode Therapeutics ASA
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
N
Nykode Therapeutics ASA
OSE:NYKD
EPS (Diluted)
$0
CAGR 3-Years
N/A
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
EPS (Diluted)
kr0
CAGR 3-Years
2%
CAGR 5-Years
-4%
CAGR 10-Years
4%
B
Bergenbio ASA
OSE:BGBIO
EPS (Diluted)
-kr3
CAGR 3-Years
-110%
CAGR 5-Years
-58%
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
EPS (Diluted)
-kr2
CAGR 3-Years
-26%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
EPS (Diluted)
kr0
CAGR 3-Years
-52%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
EPS (Diluted)
kr0
CAGR 3-Years
66%
CAGR 5-Years
53%
CAGR 10-Years
26%
No Stocks Found

Nykode Therapeutics ASA
Glance View

Market Cap
918.2m NOK
Industry
Biotechnology

Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. The company is headquartered in Oslo, Oslo and currently employs 135 full-time employees. The company went IPO on 2020-01-27. Nykode uses its vaccine technology platform to generate therapeutics in disease indications with unmet medical need. The firm develops next generation vaccines for clinical use, based on a deep understanding of immunological principles. Nykode Therapeutics’ main product candidates are VB10.16 and VB10.NEO. VB10.16 is a therapeutic cancer vaccine against HPV16-related cancers. VB10. NEO is a therapeutic cancer neoantigen vaccine. The firm also has two universal COVID-19 vaccine candidates in development.

NYKD Intrinsic Value
0.181 NOK
Overvaluation 94%
Intrinsic Value
Price
N

See Also

What is Nykode Therapeutics ASA's EPS (Diluted)?
EPS (Diluted)
-0.1 USD

Based on the financial report for Jun 30, 2024, Nykode Therapeutics ASA's EPS (Diluted) amounts to -0.1 USD.

What is Nykode Therapeutics ASA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-6%

Over the last year, the EPS (Diluted) growth was 25%.

Back to Top